- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01460732
Home Versus Ambulatory Monitoring, Diurnal Blood Pressure Profile, Detection of Non-Dippers
Home Versus Ambulatory Monitoring in the Assessment of the Diurnal Blood Pressure Profile and the Detection of Non-Dippers
This is a cross-sectional study, including adults, either untreated for hypertension, or under stable treatment for more than four weeks. Assessment will include:
Clinic blood pressure measurements with an automated oscillometric device, 24-hour ambulatory blood pressure monitoring Home blood pressure monitoring during morning, evening and nocturnal measurements with the same device.
Study Overview
Detailed Description
Eligible patients, as described in Inclusion/Exclusion Criteria, will be instructed to use Microlife WatchBP Home-Nocturnal oscillometric device, in order to measure their BP two times with one-minute interval, in the morning between 6 and 9 am and in the evening between 6 and 9 pm respectively for six days. These six days shall be normal working days, selected be the patient, within a time-frame of two weeks approximately. Patients should be sitting for at least five minutes and calm. During three out of those six days, they will apply and activate the same device, in order to take BP measurements while they will be asleep. Those measurements are going to be taken automatically by the device, the first 2-hours after the activation and another two with one-hour interval. Measurements will be averaged as awake and asleep BP values, with a potential to derive, if so wished, separate averages of awake-morning and awake-evening BP values.
Microlife WatchBP O3 Ambulatory Blood Pressure Measurement (ABPM) device will be applied by a doctor to each patient and it will be removed the next day by a doctor. BP measurements will be performed every 20 minutes for 24 hours. BP measurements taken during awake and asleep hours for each patient, will be analyzed separately.
Additionally, triplicate sitting Clinic Blood Pressure measurements, with one-minute interval, will be performed with the Microlife WatchBP Home-Nocturnal device during each patient's visit at the Hypertension Center. Patients will visit Hypertension Center three times, one to apply the ABPM device and one to remove it and provide the Microlife WatchBP Home-Nocturnal device and another one to bring it back. This will take approximately two weeks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Athens, Greece, 11527
- Sotiria General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:ma
- Patients referred for high blood pressure
- Age over 30 years
- Untreated for hypertension or under stable treatment for 4 weeks or more
- Patients physically and mentally capable for self-measurement of blood pressure at home
- Written informed consent to participate in the study
Exclusion Criteria:
- Sustained arrythmia
- Pregnancy
- Symptomatic cardiovascular disease
- Any other serious disease (renal failure, heart failure, malignancy)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: All patients
All eligible patients in the study consist a single group and the same intervention is assigned to all of them.
|
Home Blood pressure Monitoring Nocturnal-Home Blood Pressure Monitoring Ambulatory Blood Pressure Monitoring
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Awake Systolic Home Blood Pressure Measurement
Time Frame: 2 weeks
|
Awake Home Blood Pressure measurement includes duplicate BP measurements in the morning and in the evening, as per protocol.
|
2 weeks
|
Awake Diastolic Home Blood Pressure Measurement
Time Frame: 2 weeks
|
Awake Home Blood Pressure measurement includes duplicate BP measurements in the morning and in the evening, as per protocol.
|
2 weeks
|
Asleep Systolic Home Blood Pressure Measurement
Time Frame: 2 weeks
|
Home Blood Pressure measurement device was applied by the patient himself, in order to perform BP measurements during sleep, as per protocol.
|
2 weeks
|
Asleep Diastolic Home Blood Pressure Measurement
Time Frame: 2 weeks
|
Home Blood Pressure measurement device was applied by the patient himself, in order to perform BP measurements during sleep, as per protocol.
|
2 weeks
|
Awake Systolic Ambulatory Blood Pressure Measurement
Time Frame: 2 weeks
|
An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed.
Measurements taken during patient's awake and asleep hours are analyzed separately.
|
2 weeks
|
Awake Diastolic Ambulatory Blood Pressure Measurement
Time Frame: 2 weeks
|
An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed.
Measurements taken during patient's awake and asleep hours are analyzed separately.
|
2 weeks
|
Asleep Systolic Ambulatory Blood Pressure Measurement
Time Frame: 2weeks
|
An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed.
Measurements taken during patient's awake and asleep hours are analyzed separately.
|
2weeks
|
Asleep Diastolic Ambulatory Blood Pressure Measurement
Time Frame: 2weeks
|
An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed.
Measurements taken during patient's awake and asleep hours are analyzed separately.
|
2weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dippers Defined by ABPM and HBPM-Nocturnal
Time Frame: 2 weeks
|
As Dippers are defined the patients who displayed a nocturnal fall (Daytime-Nighttime BP/Daytime BP) in Systolic and/or Diastolic Blood Pressure by 10% or more, by each method.
The rest of patients, with a nocturnal fall by less than 10% or even a rise of BP, are consequently defined as Non-Dippers.
|
2 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NOCTURNAL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
Clinical Trials on Blood Pressure Monitoring
-
Queen's UniversityHeart and Stroke Foundation of OntarioCompleted
-
Consorci d'Atenció Primària de Salut de l'EixampleInstituto de Salud Carlos IIICompleted
-
University of North Carolina, Chapel HillCompletedHypertension, Pregnancy-Induced | Hypertension in Pregnancy | Blood Pressure Disorders | Postpartum PreeclampsiaUnited States
-
University of VigoUniversity of California, Los Angeles; National Institute on Minority Health... and other collaboratorsRecruiting
-
Universitätsklinikum Hamburg-EppendorfCompletedBlood Pressure | Postinduction Hypotension | Perioperative HypotensionGermany
-
Universitätsklinikum Hamburg-EppendorfCompletedBlood Pressure | Perioperative HypotensionGermany
-
University of ArkansasTerminatedPediatric Patients With SIRS (Systemic Inflammatory Response Syndrome)United States
-
University of MessinaSocieta Italiana Anestesia Analgesia Rianimazione e Terapia IntensivaRecruitingPostoperative Complications | Hemodynamic Monitoring | Blood Pressure DeterminationItaly
-
Women and Infants Hospital of Rhode IslandCompletedPreeclampsia | Gestational Hypertension | Chronic Hypertension Complicating PregnancyUnited States
-
University of AarhusCompleted